PRECIGEN, INC. Investing Cash Flow
PRECIGEN, INC. (PGEN) reported Investing Cash Flow of $47.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04
- PRECIGEN, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $26.69M, a 6.16% decline year-over-year.
- PRECIGEN, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $20.97M.
- PRECIGEN, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $39.87M.
- PRECIGEN, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$63.39M, a 1221.28% decline year-over-year.
- PRECIGEN, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$1.53M.
- PRECIGEN, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$20.71M.
- PRECIGEN, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$3.09M, a 101.36% decline from fiscal 2022.
- PRECIGEN, INC. net cash provided by (used in) investing activities for fiscal 2022 was $226.42M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $26.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $47.66M 10-Q · filed 2026-08-04 | $87.52M derived: sum of 3 quarters · filed 2026-08-04 | $24.14M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $20.97M 10-Q · filed 2026-05-13 | $60.83M derived: sum of 2 quarters · filed 2026-05-13 | -$2.55M derived: sum of 3 quarters · filed 2026-05-13 | $25.89M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $39.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$23.52M derived: sum of 2 quarters · filed 2026-03-25 | $4.92M derived: sum of 3 quarters · filed 2026-08-04 | -$1.53M 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$63.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$34.94M derived: sum of 2 quarters · filed 2026-08-04 | -$41.40M 10-Q · filed 2025-11-13 | -$106.77M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $28.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $21.98M 10-Q · filed 2026-08-04 | -$43.38M derived: sum of 3 quarters · filed 2026-08-04 | -$37.73M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$6.46M 10-Q · filed 2026-05-13 | -$71.82M derived: sum of 2 quarters · filed 2026-05-13 | -$66.17M derived: sum of 3 quarters · filed 2026-05-13 | -$51.22M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$65.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$59.71M derived: sum of 2 quarters · filed 2026-03-25 | -$44.76M derived: sum of 3 quarters · filed 2026-03-25 | -$20.71M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $20.61M derived: sum of 2 quarters · filed 2025-11-13 | $44.65M 10-Q · filed 2025-11-13 | $57.95M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-06-30 | $14.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $39.00M 10-Q · filed 2025-08-12 | $52.29M derived: sum of 3 quarters · filed 2026-03-25 | $62.82M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2024-03-31 | $24.05M 10-Q · filed 2025-05-14 | $37.34M derived: sum of 2 quarters · filed 2026-03-25 | $47.86M derived: sum of 3 quarters · filed 2026-03-25 | $71.37M derived: sum of 4 quarters · filed 2026-03-25 | |
| 2023-12-31 | $13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $23.82M derived: sum of 2 quarters · filed 2026-03-25 | $47.32M derived: sum of 3 quarters · filed 2026-03-25 | -$3.09M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $10.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $34.03M derived: sum of 2 quarters · filed 2024-11-14 | -$16.38M 10-Q · filed 2024-11-14 | -$4.96M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-06-30 | $23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$26.91M 10-Q · filed 2024-08-14 | -$15.48M derived: sum of 3 quarters · filed 2025-03-19 | $166.37M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-03-31 | -$50.41M 10-Q · filed 2024-05-14 | -$38.99M derived: sum of 2 quarters · filed 2025-03-19 | $142.87M derived: sum of 3 quarters · filed 2025-03-19 | $159.44M derived: sum of 4 quarters · filed 2025-03-19 | |
| 2022-12-31 | $11.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $193.28M derived: sum of 2 quarters · filed 2025-03-19 | $209.85M derived: sum of 3 quarters · filed 2025-03-19 | $226.42M 10-K · filed 2025-03-19 | |
| 2022-09-30 | $181.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $198.43M derived: sum of 2 quarters · filed 2023-11-09 | $215.00M 10-Q · filed 2023-11-09 | $230.93M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-06-30 | $16.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $33.14M 10-Q · filed 2023-08-09 | $49.07M derived: sum of 3 quarters · filed 2024-03-19 | $71.08M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-03-31 | $16.57M 10-Q · filed 2023-05-10 | $32.50M derived: sum of 2 quarters · filed 2024-03-19 | $54.51M derived: sum of 3 quarters · filed 2024-03-19 | $71.13M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2021-12-31 | $15.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $37.94M derived: sum of 2 quarters · filed 2024-03-19 | $54.56M derived: sum of 3 quarters · filed 2024-03-19 | -$74.54M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $22.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $38.63M derived: sum of 2 quarters · filed 2022-11-09 | -$90.47M 10-Q · filed 2022-11-09 | -$50.28M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $16.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$112.48M 10-Q · filed 2022-08-08 | -$72.30M derived: sum of 3 quarters · filed 2023-03-06 | -$72.12M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | -$129.10M 10-Q · filed 2022-05-09 | -$88.92M derived: sum of 2 quarters · filed 2023-03-06 | -$88.74M derived: sum of 3 quarters · filed 2023-03-06 | -$64.77M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $40.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $40.37M derived: sum of 2 quarters · filed 2023-03-06 | $64.33M derived: sum of 3 quarters · filed 2023-03-06 | $27.78M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $24.15M derived: sum of 2 quarters · filed 2021-11-08 | -$12.40M 10-Q · filed 2021-11-08 | $42.10M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $23.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$12.59M 10-Q · filed 2021-08-09 | $41.92M derived: sum of 3 quarters · filed 2022-03-01 | $55.70M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$36.55M 10-Q · filed 2021-05-10 | $17.96M derived: sum of 2 quarters · filed 2022-03-01 | $31.73M derived: sum of 3 quarters · filed 2022-03-01 | $16.71M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $54.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $68.29M derived: sum of 2 quarters · filed 2022-03-01 | $53.26M derived: sum of 3 quarters · filed 2022-03-01 | $86.85M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $13.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.25M derived: sum of 2 quarters · filed 2020-11-09 | $32.34M 10-Q · filed 2020-11-09 | $63.08M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$15.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $18.57M 10-Q · filed 2020-08-10 | $49.31M derived: sum of 3 quarters · filed 2021-03-01 | -$111.73M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $33.59M 10-Q · filed 2020-05-11 | $64.33M derived: sum of 2 quarters · filed 2021-03-01 | -$96.70M derived: sum of 3 quarters · filed 2021-03-01 | -$110.17M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $30.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$130.29M derived: sum of 2 quarters · filed 2021-03-01 | -$143.76M derived: sum of 3 quarters · filed 2021-03-01 | -$151.21M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$161.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$174.50M derived: sum of 2 quarters · filed 2019-11-12 | -$181.95M 10-Q · filed 2019-11-12 | -$158.04M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$13.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$20.92M 10-Q · filed 2019-08-09 | $2.99M derived: sum of 3 quarters · filed 2020-03-02 | $31.13M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$7.46M 10-Q · filed 2019-05-09 | $16.46M derived: sum of 2 quarters · filed 2020-03-02 | $44.59M derived: sum of 3 quarters · filed 2020-03-02 | $62.32M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $23.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $52.05M derived: sum of 2 quarters · filed 2020-03-02 | $69.78M derived: sum of 3 quarters · filed 2020-03-02 | $104.33M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $28.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $45.86M derived: sum of 2 quarters · filed 2018-11-08 | $80.42M 10-Q · filed 2018-11-08 | $97.17M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $17.73M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $52.28M 10-Q · filed 2018-08-13 | $69.03M derived: sum of 3 quarters · filed 2019-03-01 | $5.27M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $34.55M 10-Q/A · filed 2018-08-13 | $51.31M derived: sum of 2 quarters · filed 2019-03-01 | -$12.46M derived: sum of 3 quarters · filed 2019-03-01 | $2.28M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $16.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$47.02M derived: sum of 2 quarters · filed 2019-03-01 | -$32.27M derived: sum of 3 quarters · filed 2019-03-01 | -$28.39M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$63.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$49.02M derived: sum of 2 quarters · filed 2017-11-09 | -$45.14M 10-Q · filed 2017-11-09 | -$47.07M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | $14.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $18.62M 10-Q · filed 2017-08-09 | $16.70M derived: sum of 3 quarters · filed 2018-03-01 | -$222.81M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $3.88M 10-Q · filed 2017-05-10 | $1.95M derived: sum of 2 quarters · filed 2018-03-01 | -$237.56M derived: sum of 3 quarters · filed 2018-03-01 | -$229.33M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$241.44M derived: sum of 2 quarters · filed 2018-03-01 | -$233.21M derived: sum of 3 quarters · filed 2018-03-01 | -$259.25M 10-K · filed 2018-03-01 | -$260.81M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$239.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$231.28M derived: sum of 2 quarters · filed 2016-11-09 | -$257.32M 10-Q · filed 2016-11-09 | -$246.85M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $8.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$17.81M 10-Q · filed 2016-08-09 | -$7.34M derived: sum of 3 quarters · filed 2017-03-01 | ||
| 2015-03-31 | -$26.03M 10-Q · filed 2016-05-10 | -$15.57M derived: sum of 2 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$26.03M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | -$36.49M 10-Q · filed 2015-11-09 | ||||
| 2013-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$128.35M derived: sum of 2 quarters · filed 2016-02-29 | -$223.66M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | -$126.39M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$221.70M 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | -$95.31M 10-Q/A · filed 2013-10-21 | ||||
| 2012-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$6.71M derived: sum of 2 quarters · filed 2015-03-02 | -$23.64M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | -$170.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$17.10M 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | -$16.93M 10-Q/A · filed 2013-10-21 | ||||
| 2011-12-31 | -$64.10M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |